Pharmaceutical At-Line Monitoring

Alleviating cleanliness check downtimes for significant cost savings.

Alleviating cleanliness check downtimes for significant cost savings.

Essential to the control of cleanliness and quality, At-Line monitoring is imperative for the production of high grade pharmaceuticals without  manufacturing disruptions and excessive downtime. With over 25,000 manufacturing sites globally, and all mandated to adhere to the Current Good Manufacturing Practices to supply the US market, competition is intense.

With At-Line cleanliness testing between batches creating five days of downtime on average, implementing the ability to test on-the-spot without disruption will provide significant cost-savings and minimise supply disruption and shortages.

The GreyScan® PTD-1 has been under extensive testing with the University of Tasmania and is currently set for release in late 2021.